Dazoxiben

CAS No. 74226-22-5

Dazoxiben( UK-37248 )

Catalog No. M21159 CAS No. 74226-22-5

Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 Get Quote
5MG 84 Get Quote
10MG 140 Get Quote
25MG 290 Get Quote
50MG 520 Get Quote
100MG 750 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dazoxiben
  • Note
    Research use only, not for human use.
  • Brief Description
    Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.
  • Description
    Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UK-37248
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Thromboxane (TX) synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    74226-22-5
  • Formula Weight
    268.7
  • Molecular Formula
    C12H13ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL (232.60 mM; Need ultrasonic)
  • SMILES
    Cl.O=C(O)c1ccc(OCCn2ccnc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patrignani P Filabozzi P Catella F et al. Differential effects of dazoxiben a selective thromboxane-synthase inhibitor on platelet and renal prostaglandin-endoperoxide metabolism.[J]. journal of pharmacology & experimental therapeutics 1984 228(2):472-477.
molnova catalog
related products
  • BGC201531

    BGC201531 is a EP4 antagonist for the treatment of acute migraine.

  • E7046

    E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM. E7046 exhibits anti-tumor activities.

  • Travoprost

    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.